Colorado Naloxone for Life: Narcan Training and Distribution

Wednesday, October 12, 2016 12:31 PM
Print this page E-mail this page

The Colorado Office of the Attorney General working in partnership with the Colorado Consortium for Prescription Drug Abuse Prevention is funding the purchase of 2,500 Narcan dual-packs for law enforcement personal and first responders in 17 counties with high rates of drug overdose deaths and training in how to administer Narcan.

Law enforcement personnel and first responders who attend and complete the training and who are from the following counties will receive a FREE Narcan Rescue Kit: Adams, Baca, Bent, Clear Creek, Crowley, Delta, Dolores, Fremont, Huerfano, Jackson, Las Animas, Mesa, Otero, Ouray, Phillips, Pueblo, and Sedgwick.

Although law enforcement personnel and first responders are the primary intended audience, this two-hour training is open to any individual interested in learning how to administer Narcan, the nasal form of Naloxone. The training is free to attend and registration is required. To register, visit: http://bit.ly/CONFL

Participants will be trained on how to properly identify symptoms and conditions of opioid overdose and will learn the proper methods for administering Narcan.

The instructors will offer train-the-trainer content so agencies can provide this important training in-house in the future. Although law enforcement personnel and first responders from outside of the 17-counties will not be provided the Narcan inhalers, they are encouraged to attend the training, including the train-the-trainer instruction to take back to their agencies. This two-hour class will be offered two to three times in each location depending on demand and is open to all law enforcement personnel and first responders, including fire EMS and hospital personnel and open to the general public. Each session is limited to 40 participants, but if a waitlist develops another session will be added.


Posted in: ASAP | Initiatives | Prescription Drug Abuse
 

Comments

Please sign in to view or post comments.